Tirzepatide reduced the risk of developing type 2 diabetes by 94% in adults with pre-diabetes and obesity or overweight

Go back to Tirzepatide reduced the risk of developing type 2 diabetes by 94% in adults with pre-diabetes and obesity or overweight

Eli Lilly (LLY) is a new large-cap pharma top pick at Wells Fargo

August 20, 2024 12:05 PM EDT

Wells Fargo named Eli Lilly & Co. (NYSE: LLY) as its new top pick among large-cap pharmaceutical stocks in a note to clients Tuesday, highlighting the company's potential for significant upside.

In a recent update to its large-cap rankings, Wells Fargo analysts stressed the strength of Eli Lilly's pipeline and its ability to exceed market expectations in the... More